title
stringlengths 4
295
⌀ | pmid
stringlengths 8
8
| background_abstract
stringlengths 12
1.65k
| background_abstract_label
stringclasses 12
values | methods_abstract
stringlengths 39
1.48k
| methods_abstract_label
stringlengths 6
31
| results_abstract
stringlengths 65
1.93k
| results_abstract_label
stringclasses 10
values | conclusions_abstract
stringlengths 57
1.02k
| conclusions_abstract_label
stringclasses 22
values | mesh_descriptor_names
sequence | pmcid
stringlengths 6
8
| background_title
stringlengths 10
86
⌀ | background_text
stringlengths 215
23.3k
⌀ | methods_title
stringlengths 6
74
⌀ | methods_text
stringlengths 99
42.9k
⌀ | results_title
stringlengths 6
172
⌀ | results_text
stringlengths 141
62.9k
⌀ | conclusions_title
stringlengths 9
44
⌀ | conclusions_text
stringlengths 5
13.6k
⌀ | other_sections_titles
sequence | other_sections_texts
sequence | other_sections_sec_types
sequence | all_sections_titles
sequence | all_sections_texts
sequence | all_sections_sec_types
sequence | keywords
sequence | whole_article_text
stringlengths 6.93k
126k
| whole_article_abstract
stringlengths 936
2.95k
| background_conclusion_text
stringlengths 587
24.7k
⌀ | background_conclusion_abstract
stringlengths 936
2.83k
⌀ | whole_article_text_length
int64 1.3k
22.5k
| whole_article_abstract_length
int64 183
490
| other_sections_lengths
sequence | num_sections
int64 3
28
| most_frequent_words
sequence | keybert_topics
sequence | annotated_base_background_abstract_prompt
stringclasses 1
value | annotated_base_methods_abstract_prompt
stringclasses 1
value | annotated_base_results_abstract_prompt
stringclasses 1
value | annotated_base_conclusions_abstract_prompt
stringclasses 1
value | annotated_base_whole_article_abstract_prompt
stringclasses 1
value | annotated_base_background_conclusion_abstract_prompt
stringclasses 1
value | annotated_keywords_background_abstract_prompt
stringlengths 28
460
⌀ | annotated_keywords_methods_abstract_prompt
stringlengths 28
701
⌀ | annotated_keywords_results_abstract_prompt
stringlengths 28
701
⌀ | annotated_keywords_conclusions_abstract_prompt
stringlengths 28
428
⌀ | annotated_keywords_whole_article_abstract_prompt
stringlengths 28
701
| annotated_keywords_background_conclusion_abstract_prompt
stringlengths 28
428
⌀ | annotated_mesh_background_abstract_prompt
stringlengths 53
701
⌀ | annotated_mesh_methods_abstract_prompt
stringlengths 53
701
⌀ | annotated_mesh_results_abstract_prompt
stringlengths 53
692
⌀ | annotated_mesh_conclusions_abstract_prompt
stringlengths 54
701
⌀ | annotated_mesh_whole_article_abstract_prompt
stringlengths 53
701
| annotated_mesh_background_conclusion_abstract_prompt
stringlengths 54
701
⌀ | annotated_keybert_background_abstract_prompt
stringlengths 100
219
⌀ | annotated_keybert_methods_abstract_prompt
stringlengths 100
219
⌀ | annotated_keybert_results_abstract_prompt
stringlengths 101
219
⌀ | annotated_keybert_conclusions_abstract_prompt
stringlengths 100
240
⌀ | annotated_keybert_whole_article_abstract_prompt
stringlengths 100
240
| annotated_keybert_background_conclusion_abstract_prompt
stringlengths 100
211
⌀ | annotated_most_frequent_background_abstract_prompt
stringlengths 67
217
⌀ | annotated_most_frequent_methods_abstract_prompt
stringlengths 67
217
⌀ | annotated_most_frequent_results_abstract_prompt
stringlengths 67
217
⌀ | annotated_most_frequent_conclusions_abstract_prompt
stringlengths 71
217
⌀ | annotated_most_frequent_whole_article_abstract_prompt
stringlengths 67
217
| annotated_most_frequent_background_conclusion_abstract_prompt
stringlengths 71
217
⌀ | annotated_tf_idf_background_abstract_prompt
stringlengths 74
283
⌀ | annotated_tf_idf_methods_abstract_prompt
stringlengths 67
325
⌀ | annotated_tf_idf_results_abstract_prompt
stringlengths 69
340
⌀ | annotated_tf_idf_conclusions_abstract_prompt
stringlengths 83
403
⌀ | annotated_tf_idf_whole_article_abstract_prompt
stringlengths 70
254
| annotated_tf_idf_background_conclusion_abstract_prompt
stringlengths 71
254
⌀ | annotated_entity_plan_background_abstract_prompt
stringlengths 20
313
⌀ | annotated_entity_plan_methods_abstract_prompt
stringlengths 20
452
⌀ | annotated_entity_plan_results_abstract_prompt
stringlengths 20
596
⌀ | annotated_entity_plan_conclusions_abstract_prompt
stringlengths 20
150
⌀ | annotated_entity_plan_whole_article_abstract_prompt
stringlengths 50
758
| annotated_entity_plan_background_conclusion_abstract_prompt
stringlengths 50
758
⌀ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
"Effects of oral alkali drug therapy on clinical outcomes in pre-dialysis chronic kidney disease pat(...TRUNCATED) | 35176947 | "Metabolic acidosis accelerates the progression of chronic kidney disease (CKD) and increases the mo(...TRUNCATED) | BACKGROUND | "We systematically searched MEDLINE using the Ovid, EMBASE, and Cochrane Library databases without l(...TRUNCATED) | METHODS | "A total of 18 eligible studies, including 14 randomized controlled trials and 4 cohort studies repo(...TRUNCATED) | RESULTS | "Based on the available and low-to-moderate certainty evidence, oral alkali drug therapy might poten(...TRUNCATED) | CONCLUSION | ["Acidosis","Administration, Oral","Adult","Alkalies","Cause of Death","Disease Progression","Glomer(...TRUNCATED) | 8865123 | Introduction | "Metabolic acidosis (MA), a common complication of chronic kidney disease (CKD) caused by failure to(...TRUNCATED) | null | null | Results | "Overview of included trials The literature search yielded 9284 potentially relevant records, of whi(...TRUNCATED) | null | null | ["Data sources and search strategy","Study selection and outcome estimation","Data extraction and qu(...TRUNCATED) | ["We performed this systematic review according to a pre-specified protocol [9] registered in the In(...TRUNCATED) | [
null,
null,
null,
null,
null,
null,
null,
null
] | ["Introduction","Materials and methods","Data sources and search strategy","Study selection and outc(...TRUNCATED) | ["Metabolic acidosis (MA), a common complication of chronic kidney disease (CKD) caused by failure t(...TRUNCATED) | ["intro","materials",null,null,null,null,"results",null,null,null,null,"discussion","supplementary-m(...TRUNCATED) | ["Oral alkali drug therapy","pre-dialysis chronic kidney disease","meta-analysis","renal outcomes","(...TRUNCATED) | "Introduction:\nMetabolic acidosis (MA), a common complication of chronic kidney disease (CKD) cause(...TRUNCATED) | "Background:\nMetabolic acidosis accelerates the progression of chronic kidney disease (CKD) and inc(...TRUNCATED) | null | null | 8,900 | 341 | [
178,
237,
250,
424,
316,
541,
240,
51
] | 13 | [
"studies",
"events",
"alkali",
"data",
"oral",
"oral alkali",
"egfr",
"risk",
"included",
"therapy"
] | ["oral bicarbonate supplementation","bicarbonate supplementation risk","effects alkali supplementati(...TRUNCATED) | null | null | null | "[CONTENT] Oral alkali drug therapy | pre-dialysis chronic kidney disease | meta-analysis | renal ou(...TRUNCATED) | null | "[CONTENT] Oral alkali drug therapy | pre-dialysis chronic kidney disease | meta-analysis | renal ou(...TRUNCATED) | null | "[CONTENT] Oral alkali drug therapy | pre-dialysis chronic kidney disease | meta-analysis | renal ou(...TRUNCATED) | null | "[CONTENT] Acidosis | Administration, Oral | Adult | Alkalies | Cause of Death | Disease Progression(...TRUNCATED) | null | "[CONTENT] Acidosis | Administration, Oral | Adult | Alkalies | Cause of Death | Disease Progression(...TRUNCATED) | null | "[CONTENT] Acidosis | Administration, Oral | Adult | Alkalies | Cause of Death | Disease Progression(...TRUNCATED) | null | "[CONTENT] oral bicarbonate supplementation | bicarbonate supplementation risk | effects alkali supp(...TRUNCATED) | null | "[CONTENT] oral bicarbonate supplementation | bicarbonate supplementation risk | effects alkali supp(...TRUNCATED) | null | "[CONTENT] oral bicarbonate supplementation | bicarbonate supplementation risk | effects alkali supp(...TRUNCATED) | null | "[CONTENT] studies | events | alkali | data | oral | oral alkali | egfr | risk | included | therapy (...TRUNCATED) | null | "[CONTENT] studies | events | alkali | data | oral | oral alkali | egfr | risk | included | therapy (...TRUNCATED) | null | "[CONTENT] studies | events | alkali | data | oral | oral alkali | egfr | risk | included | therapy (...TRUNCATED) | null | "[CONTENT] ckd | ma | supplementation | ckd patients | patients | bicarbonate | mortality | progress(...TRUNCATED) | null | "[CONTENT] events | significant | ci | table | heterogeneity | supplementary | supplementary table |(...TRUNCATED) | null | "[CONTENT] studies | events | data | risk | egfr | ckd | alkali | bias | oral | significant [SUMMARY(...TRUNCATED) | null | [CONTENT] ||| ||| [SUMMARY] | null | "[CONTENT] 18 | 14 | 4 | 19 | 3695 ||| 55% | 0.45 | 95% | CI | 0.25-0.82 | 2.59 mL | 95% | CI | 0.(...TRUNCATED) | null | "[CONTENT] ||| ||| ||| MEDLINE | Ovid | EMBASE | Cochrane Library ||| CKD ||| ||| 18 | 14 | 4 | (...TRUNCATED) | null |
|||
"Survey about Intention to Engage in Specific Disaster Activities among Disaster Medical Assistance (...TRUNCATED) | 34658320 | "Different disaster activities should be performed smoothly. In relation to this, human resources fo(...TRUNCATED) | INTRODUCTION | "An anonymous web questionnaire survey was conducted. Japanese DMAT members in the nuclear disaster-(...TRUNCATED) | METHODS | "The intention to engage in C (50), B (47), R/N (58), and E (52) disasters was significantly lower t(...TRUNCATED) | RESULTS | "Experience with a specific type of calamity at a young age may improve intention to engage in not o(...TRUNCATED) | CONCLUSION | ["Adult","Disaster Planning","Disasters","Humans","Intention","Medical Assistance","Surveys and Ques(...TRUNCATED) | 8607140 | Introduction | "In patients with critical conditions, the initial response of the rapid response team or medical em(...TRUNCATED) | Methods | "This was a cross-sectional study. An anonymous web questionnaire survey was conducted from October (...TRUNCATED) | Results | "The characteristics of younger participants in Group A (n = 28), younger participants in Group N (n(...TRUNCATED) | Conclusion | "Japanese DMAT members had a low intention to engage in CBRNE disaster activities compared with natu(...TRUNCATED) | [
"Ethics Committee Approval"
] | ["The ethics committee of Fukushima Medical University approved the study protocol (Fukushima, Japan(...TRUNCATED) | [
"other"
] | ["Introduction","Methods","Ethics Committee Approval","Results","Discussion","Limitations","Conclusi(...TRUNCATED) | ["In patients with critical conditions, the initial response of the rapid response team or medical e(...TRUNCATED) | [
"intro",
"methods",
"other",
"results",
"discussion",
"other",
"conclusions"
] | [
"disaster",
"emergency responders",
"hazard",
"human resources",
"intention"
] | "Introduction:\nIn patients with critical conditions, the initial response of the rapid response tea(...TRUNCATED) | "Background:\nDifferent disaster activities should be performed smoothly. In relation to this, human(...TRUNCATED) | "Introduction:\nIn patients with critical conditions, the initial response of the rapid response tea(...TRUNCATED) | "Background:\nDifferent disaster activities should be performed smoothly. In relation to this, human(...TRUNCATED) | 5,056 | 442 | [
24
] | 7 | ["group","disaster","sd","disasters","eis","engage","nuclear","participants","affected","activities"(...TRUNCATED) | ["nuclear disaster activities","firefighters nuclear disaster","disaster medical","radiological nucl(...TRUNCATED) | [CONTENT] disaster | emergency responders | hazard | human resources | intention [SUMMARY] | [CONTENT] disaster | emergency responders | hazard | human resources | intention [SUMMARY] | [CONTENT] disaster | emergency responders | hazard | human resources | intention [SUMMARY] | [CONTENT] disaster | emergency responders | hazard | human resources | intention [SUMMARY] | [CONTENT] disaster | emergency responders | hazard | human resources | intention [SUMMARY] | [CONTENT] disaster | emergency responders | hazard | human resources | intention [SUMMARY] | "[CONTENT] Adult | Disaster Planning | Disasters | Humans | Intention | Medical Assistance | Surveys(...TRUNCATED) | "[CONTENT] Adult | Disaster Planning | Disasters | Humans | Intention | Medical Assistance | Surveys(...TRUNCATED) | "[CONTENT] Adult | Disaster Planning | Disasters | Humans | Intention | Medical Assistance | Surveys(...TRUNCATED) | "[CONTENT] Adult | Disaster Planning | Disasters | Humans | Intention | Medical Assistance | Surveys(...TRUNCATED) | "[CONTENT] Adult | Disaster Planning | Disasters | Humans | Intention | Medical Assistance | Surveys(...TRUNCATED) | "[CONTENT] Adult | Disaster Planning | Disasters | Humans | Intention | Medical Assistance | Surveys(...TRUNCATED) | "[CONTENT] nuclear disaster activities | firefighters nuclear disaster | disaster medical | radiolog(...TRUNCATED) | "[CONTENT] nuclear disaster activities | firefighters nuclear disaster | disaster medical | radiolog(...TRUNCATED) | "[CONTENT] nuclear disaster activities | firefighters nuclear disaster | disaster medical | radiolog(...TRUNCATED) | "[CONTENT] nuclear disaster activities | firefighters nuclear disaster | disaster medical | radiolog(...TRUNCATED) | "[CONTENT] nuclear disaster activities | firefighters nuclear disaster | disaster medical | radiolog(...TRUNCATED) | "[CONTENT] nuclear disaster activities | firefighters nuclear disaster | disaster medical | radiolog(...TRUNCATED) | "[CONTENT] group | disaster | sd | disasters | eis | engage | nuclear | participants | affected | ac(...TRUNCATED) | "[CONTENT] group | disaster | sd | disasters | eis | engage | nuclear | participants | affected | ac(...TRUNCATED) | "[CONTENT] group | disaster | sd | disasters | eis | engage | nuclear | participants | affected | ac(...TRUNCATED) | "[CONTENT] group | disaster | sd | disasters | eis | engage | nuclear | participants | affected | ac(...TRUNCATED) | "[CONTENT] group | disaster | sd | disasters | eis | engage | nuclear | participants | affected | ac(...TRUNCATED) | "[CONTENT] group | disaster | sd | disasters | eis | engage | nuclear | participants | affected | ac(...TRUNCATED) | "[CONTENT] disaster | response | activities | disasters | disaster activities | nuclear | medical | (...TRUNCATED) | "[CONTENT] area | affected | group | affected area | disaster | participants | non affected area | n(...TRUNCATED) | "[CONTENT] sd | group | 35 | sd 35 | older | participants | disaster | younger | 05 | participants g(...TRUNCATED) | "[CONTENT] activities | disaster activities | disaster | intention engage cbrne disaster | intention(...TRUNCATED) | "[CONTENT] disaster | group | disasters | activities | sd | disaster activities | engage | cbrne | i(...TRUNCATED) | "[CONTENT] disaster | group | disasters | activities | sd | disaster activities | engage | cbrne | i(...TRUNCATED) | [CONTENT] ||| ||| ||| Disaster Medical Assistance Team (DMAT [SUMMARY] | [CONTENT] ||| Japanese | DMAT | Group A | 79 | Group N | 99 ||| ||| [SUMMARY] | "[CONTENT] 50 | R/N | 58 | 52 | 82 | 82 ||| CBRNE | age ≤39 years | Group A | Group N. By | Group (...TRUNCATED) | [CONTENT] ||| CBRNE ||| CBRNE | DMAT [SUMMARY] | "[CONTENT] ||| ||| ||| Disaster Medical Assistance Team (DMAT ||| ||| Japanese | DMAT | Group A (...TRUNCATED) | "[CONTENT] ||| ||| ||| Disaster Medical Assistance Team (DMAT ||| ||| Japanese | DMAT | Group A (...TRUNCATED) |
||||||
"Comparison of 4 Methods for Dynamization of Locking Plates: Differences in the Amount and Type of F(...TRUNCATED) | 28657927 | "Decreasing the stiffness of locked plating constructs can promote natural fracture healing by contr(...TRUNCATED) | BACKGROUND | "Distal femur locking plates were applied to bridge a metadiaphyseal fracture in femur surrogates. A(...TRUNCATED) | METHODS | "Compared with LOCKED control constructs, NONLOCKED constructs had a similar stiffness (P = 0.08), a(...TRUNCATED) | RESULTS | "In a surrogate model of a distal femur fracture, replacing locked with nonlocked diaphyseal screws (...TRUNCATED) | CONCLUSIONS | ["Biomechanical Phenomena","Bone Plates","Bone Screws","Diaphyses","Equipment Design","Femoral Fract(...TRUNCATED) | 5603978 | INTRODUCTION | "Angle-stable locked plating has become the standard treatment for most difficult fractures of the d(...TRUNCATED) | null | null | RESULTS | " Construct Stiffness There was no significant difference between the stiffness of LOCKED control c(...TRUNCATED) | null | null | ["Specimens","Loading","Outcome Assessment","Statistical Analysis","Construct Stiffness","Axial Inte(...TRUNCATED) | ["Plating constructs were evaluated in fourth generation femur surrogate specimens made of fiber-rei(...TRUNCATED) | [
null,
null,
null,
null,
null,
null,
null
] | ["INTRODUCTION","MATERIAL AND METHODS","Specimens","Loading","Outcome Assessment","Statistical Analy(...TRUNCATED) | ["Angle-stable locked plating has become the standard treatment for most difficult fractures of the (...TRUNCATED) | ["intro","materials|methods",null,null,null,null,"results",null,null,null,"discussion","supplementar(...TRUNCATED) | ["plate fixation","locked plating","dynamization","interfragmentary motion","stiffness","active plat(...TRUNCATED) | "INTRODUCTION:\nAngle-stable locked plating has become the standard treatment for most difficult fra(...TRUNCATED) | "Background:\nDecreasing the stiffness of locked plating constructs can promote natural fracture hea(...TRUNCATED) | null | null | 7,145 | 332 | [
694,
169,
215,
88,
133,
257,
156
] | 12 | [
"motion",
"group",
"plate",
"constructs",
"locked",
"mm",
"fracture",
"construct",
"locking",
"cortex"
] | ["locked distal femur","fracture healing inhibited","fracture fixation osteopenic","fracture motion (...TRUNCATED) | null | null | null | "[CONTENT] plate fixation | locked plating | dynamization | interfragmentary motion | stiffness | ac(...TRUNCATED) | null | "[CONTENT] plate fixation | locked plating | dynamization | interfragmentary motion | stiffness | ac(...TRUNCATED) | null | "[CONTENT] plate fixation | locked plating | dynamization | interfragmentary motion | stiffness | ac(...TRUNCATED) | null | "[CONTENT] Biomechanical Phenomena | Bone Plates | Bone Screws | Diaphyses | Equipment Design | Femo(...TRUNCATED) | null | "[CONTENT] Biomechanical Phenomena | Bone Plates | Bone Screws | Diaphyses | Equipment Design | Femo(...TRUNCATED) | null | "[CONTENT] Biomechanical Phenomena | Bone Plates | Bone Screws | Diaphyses | Equipment Design | Femo(...TRUNCATED) | null | "[CONTENT] locked distal femur | fracture healing inhibited | fracture fixation osteopenic | fractur(...TRUNCATED) | null | "[CONTENT] locked distal femur | fracture healing inhibited | fracture fixation osteopenic | fractur(...TRUNCATED) | null | "[CONTENT] locked distal femur | fracture healing inhibited | fracture fixation osteopenic | fractur(...TRUNCATED) | null | "[CONTENT] motion | group | plate | constructs | locked | mm | fracture | construct | locking | cort(...TRUNCATED) | null | "[CONTENT] motion | group | plate | constructs | locked | mm | fracture | construct | locking | cort(...TRUNCATED) | null | "[CONTENT] motion | group | plate | constructs | locked | mm | fracture | construct | locking | cort(...TRUNCATED) | null | "[CONTENT] healing | fracture | fracture healing | mechanical | motion | plating | fixation | dynami(...TRUNCATED) | null | "[CONTENT] group | 001 | motion | group 001 | greater | locked control | control | locked | mm | con(...TRUNCATED) | null | "[CONTENT] motion | group | constructs | locked | plate | mm | fracture | da | cortex | stiffness [S(...TRUNCATED) | null | [CONTENT] ||| 4 [SUMMARY] | null | [CONTENT] NONLOCKED | 0.08 | 0.07 | 0.97 ||| 45% ||| FCL | 62% | 75% [SUMMARY] | null | "[CONTENT] ||| 4 ||| ||| ||| Four | 2 ||| ||| NONLOCKED | 0.08 | 0.07 | 0.97 ||| 45% ||| FCL | 6(...TRUNCATED) | null |
|||
"Efficacy and safety of endoscopic submucosal dissection for gastric tube cancer: A multicenter retr(...TRUNCATED) | 33776371 | "Recent improvements in the prognosis of patients with esophageal cancer have led to the increased o(...TRUNCATED) | BACKGROUND | "We retrospectively investigated 48 GTC lesions in 38 consecutive patients with GTC in the reconstru(...TRUNCATED) | METHODS | "The median age of patients was 71.5 years (range, 57-84years), and there were 34 men and 4 women. T(...TRUNCATED) | RESULTS | ESD for GTC after esophagectomy was shown to be safe and effective. | CONCLUSION | ["Aged","Aged, 80 and over","Dissection","Endoscopic Mucosal Resection","Female","Gastric Mucosa","H(...TRUNCATED) | 7985736 | INTRODUCTION | "Recently, the survival of patients with esophageal cancer after esophagectomy has improved[1-5]. Ho(...TRUNCATED) | MATERIALS AND METHODS | "Patients We retrospectively investigated patients with GTC in the reconstructed gastric tube after (...TRUNCATED) | null | null | CONCLUSION | "As some patients were observed for only a short time, the assessment of long-term prognosis after E(...TRUNCATED) | ["INTRODUCTION","Patients","Endoscopic procedures","Histopathological assessment of curability","Sta(...TRUNCATED) | ["Recently, the survival of patients with esophageal cancer after esophagectomy has improved[1-5]. H(...TRUNCATED) | [
null,
null,
null,
null,
null,
null,
null,
null,
null,
null,
null,
null,
null
] | ["INTRODUCTION","MATERIALS AND METHODS","Patients","Endoscopic procedures","Histopathological assess(...TRUNCATED) | ["Recently, the survival of patients with esophageal cancer after esophagectomy has improved[1-5]. H(...TRUNCATED) | [
null,
"methods",
null,
null,
null,
null,
null,
null,
null,
null,
null,
null,
null,
null
] | ["Endoscopic submucosal dissection","Gastric tube","Gastric cancer","Eso-phagectomy","Multicenter st(...TRUNCATED) | "INTRODUCTION:\nRecently, the survival of patients with esophageal cancer after esophagectomy has im(...TRUNCATED) | "Background:\nRecent improvements in the prognosis of patients with esophageal cancer have led to th(...TRUNCATED) | "INTRODUCTION:\nRecently, the survival of patients with esophageal cancer after esophagectomy has im(...TRUNCATED) | "Background:\nRecent improvements in the prognosis of patients with esophageal cancer have led to th(...TRUNCATED) | 7,384 | 349 | [
391,
190,
257,
136,
115,
2564,
235,
313,
297,
155,
266,
917,
55
] | 14 | ["esd","patients","gtc","gastric","submucosal","treatment","endoscopic","cancer","lesions","resectio(...TRUNCATED) | ["gtc esophagectomy total","gtc esophagectomy pathological","review gtc esophagectomy","gastric tube(...TRUNCATED) | null | "[CONTENT] Endoscopic submucosal dissection | Gastric tube | Gastric cancer | Eso-phagectomy | Multi(...TRUNCATED) | "[CONTENT] Endoscopic submucosal dissection | Gastric tube | Gastric cancer | Eso-phagectomy | Multi(...TRUNCATED) | null | "[CONTENT] Endoscopic submucosal dissection | Gastric tube | Gastric cancer | Eso-phagectomy | Multi(...TRUNCATED) | "[CONTENT] Endoscopic submucosal dissection | Gastric tube | Gastric cancer | Eso-phagectomy | Multi(...TRUNCATED) | "[CONTENT] Endoscopic submucosal dissection | Gastric tube | Gastric cancer | Eso-phagectomy | Multi(...TRUNCATED) | "[CONTENT] Aged | Aged, 80 and over | Dissection | Endoscopic Mucosal Resection | Female | Gastric M(...TRUNCATED) | "[CONTENT] Aged | Aged, 80 and over | Dissection | Endoscopic Mucosal Resection | Female | Gastric M(...TRUNCATED) | null | "[CONTENT] Aged | Aged, 80 and over | Dissection | Endoscopic Mucosal Resection | Female | Gastric M(...TRUNCATED) | "[CONTENT] Aged | Aged, 80 and over | Dissection | Endoscopic Mucosal Resection | Female | Gastric M(...TRUNCATED) | "[CONTENT] Aged | Aged, 80 and over | Dissection | Endoscopic Mucosal Resection | Female | Gastric M(...TRUNCATED) | "[CONTENT] gtc esophagectomy total | gtc esophagectomy pathological | review gtc esophagectomy | gas(...TRUNCATED) | "[CONTENT] gtc esophagectomy total | gtc esophagectomy pathological | review gtc esophagectomy | gas(...TRUNCATED) | null | "[CONTENT] gtc esophagectomy total | gtc esophagectomy pathological | review gtc esophagectomy | gas(...TRUNCATED) | "[CONTENT] gtc esophagectomy total | gtc esophagectomy pathological | review gtc esophagectomy | gas(...TRUNCATED) | "[CONTENT] gtc esophagectomy total | gtc esophagectomy pathological | review gtc esophagectomy | gas(...TRUNCATED) | "[CONTENT] esd | patients | gtc | gastric | submucosal | treatment | endoscopic | cancer | lesions |(...TRUNCATED) | "[CONTENT] esd | patients | gtc | gastric | submucosal | treatment | endoscopic | cancer | lesions |(...TRUNCATED) | null | "[CONTENT] esd | patients | gtc | gastric | submucosal | treatment | endoscopic | cancer | lesions |(...TRUNCATED) | "[CONTENT] esd | patients | gtc | gastric | submucosal | treatment | endoscopic | cancer | lesions |(...TRUNCATED) | "[CONTENT] esd | patients | gtc | gastric | submucosal | treatment | endoscopic | cancer | lesions |(...TRUNCATED) | "[CONTENT] gtc | cancer | esophagectomy | esd | resection | high | esd gtc | gastric | gtc esophagec(...TRUNCATED) | "[CONTENT] knife | knife knife | tokyo japan | japan | tokyo | curative | resection | study | ecura (...TRUNCATED) | null | "[CONTENT] significant variability treatment | accumulation follow cases gtc | expertise accumulatio(...TRUNCATED) | "[CONTENT] esd | patients | gtc | knife | gastric | resection | lesions | submucosal | treatment | c(...TRUNCATED) | "[CONTENT] esd | patients | gtc | knife | gastric | resection | lesions | submucosal | treatment | c(...TRUNCATED) | [CONTENT] GTC ||| ESD | GTC [SUMMARY] | "[CONTENT] 48 | GTC | 38 | GTC | ESD | between January 2005 | December 2019 | 8 ||| ESD | GTC ||| ES(...TRUNCATED) | null | [CONTENT] ESD | GTC [SUMMARY] | "[CONTENT] GTC ||| ESD | GTC ||| 48 | GTC | 38 | GTC | ESD | between January 2005 | December 2019 | (...TRUNCATED) | "[CONTENT] GTC ||| ESD | GTC ||| 48 | GTC | 38 | GTC | ESD | between January 2005 | December 2019 | (...TRUNCATED) |
|||||
"OATP1B1 and tumour OATP1B3 modulate exposure, toxicity, and survival after irinotecan-based chemoth(...TRUNCATED) | 25611302 | "Treatment of advanced and metastatic colorectal cancer with irinotecan is hampered by severe toxici(...TRUNCATED) | BACKGROUND | "Blood samples (n=127) and tumour tissue (n=30) were obtained from advanced cancer patients treated (...TRUNCATED) | METHODS | "SLCO1B1 521C was significantly associated with increased SN-38 exposure (P<0.001), which was additi(...TRUNCATED) | RESULTS | "Clarifying the association of host genetic variation in OATP and ABC transporters to SN-38 exposure(...TRUNCATED) | CONCLUSIONS | ["Adult","Aged","Aged, 80 and over","Antineoplastic Agents, Phytogenic","Camptothecin","Colorectal N(...TRUNCATED) | 4453959 | null | null | null | null | Results | " Study population Patient and tumour characteristics (n=127) are described in Table 1. The treatme(...TRUNCATED) | null | null | ["Study population","Chart review","Genotyping","Drug levels","Immunohistochemistry","Statistics","S(...TRUNCATED) | ["Metastatic colorectal cancer and advanced or metastatic pancreatic cancer patients (n=127) being t(...TRUNCATED) | [
null,
null,
null,
null,
null,
null,
null,
null,
null,
null,
null
] | ["Materials and Methods","Study population","Chart review","Genotyping","Drug levels","Immunohistoch(...TRUNCATED) | [" Study population Metastatic colorectal cancer and advanced or metastatic pancreatic cancer patie(...TRUNCATED) | [
"materials|methods",
null,
null,
null,
null,
null,
null,
"results",
null,
null,
null,
null,
null,
"discussion"
] | [
"OATP1B1",
"OATP1B3",
"Irinotecan",
"SN-38",
"colorectal cancer"
] | "Materials and Methods:\n Study population Metastatic colorectal cancer and advanced or metastatic (...TRUNCATED) | "Background:\nTreatment of advanced and metastatic colorectal cancer with irinotecan is hampered by (...TRUNCATED) | null | null | 10,545 | 266 | [
172,
263,
191,
350,
192,
443,
68,
507,
314,
206,
202
] | 14 | [
"patients",
"11",
"cpt 11",
"cpt",
"sn",
"38",
"sn 38",
"grade",
"analysis",
"28"
] | ["chemotherapy regimens scored","chemotherapy majority patients","folfiri chemotherapy regimens","me(...TRUNCATED) | null | null | null | null | null | null | [CONTENT] OATP1B1 | OATP1B3 | Irinotecan | SN-38 | colorectal cancer [SUMMARY] | null | [CONTENT] OATP1B1 | OATP1B3 | Irinotecan | SN-38 | colorectal cancer [SUMMARY] | null | null | null | "[CONTENT] Adult | Aged | Aged, 80 and over | Antineoplastic Agents, Phytogenic | Camptothecin | Col(...TRUNCATED) | null | "[CONTENT] Adult | Aged | Aged, 80 and over | Antineoplastic Agents, Phytogenic | Camptothecin | Col(...TRUNCATED) | null | null | null | "[CONTENT] chemotherapy regimens scored | chemotherapy majority patients | folfiri chemotherapy regi(...TRUNCATED) | null | "[CONTENT] chemotherapy regimens scored | chemotherapy majority patients | folfiri chemotherapy regi(...TRUNCATED) | null | null | null | [CONTENT] patients | 11 | cpt 11 | cpt | sn | 38 | sn 38 | grade | analysis | 28 [SUMMARY] | null | [CONTENT] patients | 11 | cpt 11 | cpt | sn | 38 | sn 38 | grade | analysis | 28 [SUMMARY] | null | null | null | "[CONTENT] patients | sn | 95 | table | ci | 95 ci | significantly | levels | 28 | compared [SUMMARY(...TRUNCATED) | null | [CONTENT] patients | 11 | cpt | cpt 11 | sn | table | grade | oatp1b3 | 95 | analysis [SUMMARY] | null | null | null | "[CONTENT] 521C | 28 ||| ABCC5 | rs562 | SN-38 | APC ||| ABCC2-24C/T | 0.06-0.85 | CES1 | OR=0.29 | (...TRUNCATED) | null | "[CONTENT] irinotecan ||| irinotecan | SN-38 | ABC ||| irinotecan ||| ||| ||| 521C | 28 ||| ABCC5 (...TRUNCATED) | null |
||
"A model to explain the challenges of emergency medical technicians' decision making process in emer(...TRUNCATED) | 35067498 | "To manage life-threatening conditions and reduce morbidity and mortality, pre-hospital's on-scene d(...TRUNCATED) | BACKGROUND | "This study was applied through grounded theory method using direct field observations and semi-stru(...TRUNCATED) | METHODS | "A paradigm model was developed to explain the relationships among the main categories. Decision mak(...TRUNCATED) | RESULTS | "Based on the finding of this study, Emergency Medical technicians' decision making in the context o(...TRUNCATED) | CONCLUSIONS | ["Decision Making","Emergency Medical Services","Emergency Medical Technicians","Grounded Theory","H(...TRUNCATED) | 9115813 | Introduction | "Emergency Medical Services (EMS) centers were established to provide on-time and rapid services to (...TRUNCATED) | Methods | "\nStudy setting\n\nIn Iran, national EMS system provides free services for patients and injured peo(...TRUNCATED) | Results | "This study explored the EMTS 'on-scene decision making process. In the initial analysis, 1352 codes(...TRUNCATED) | Conclusion | "This study designed a paradigm model to explain the process and to explore the relationships betwee(...TRUNCATED) | [] | [] | [] | [
"Introduction",
"Methods ",
"Results",
"Discussion",
"Conclusion"
] | ["Emergency Medical Services (EMS) centers were established to provide on-time and rapid services to(...TRUNCATED) | [
"introduction",
"methods",
"results",
"discussion",
"conclusion"
] | ["Emergency medical services","Emergency medical technician","Decision making","Pre-hospital","Iran (...TRUNCATED) | "Introduction:\nEmergency Medical Services (EMS) centers were established to provide on-time and rap(...TRUNCATED) | "Background:\nTo manage life-threatening conditions and reduce morbidity and mortality, pre-hospital(...TRUNCATED) | "Introduction:\nEmergency Medical Services (EMS) centers were established to provide on-time and rap(...TRUNCATED) | "Background:\nTo manage life-threatening conditions and reduce morbidity and mortality, pre-hospital(...TRUNCATED) | 5,613 | 348 | [] | 5 | ["emts","decision","making","decision making","scene","emergency","medical","hospital","study","pati(...TRUNCATED) | ["effect emts decisions","emergency care concluded","services emts emergency","emt decision making",(...TRUNCATED) | "[CONTENT] Emergency medical services | Emergency medical technician | Decision making | Pre-hospita(...TRUNCATED) | "[CONTENT] Emergency medical services | Emergency medical technician | Decision making | Pre-hospita(...TRUNCATED) | "[CONTENT] Emergency medical services | Emergency medical technician | Decision making | Pre-hospita(...TRUNCATED) | "[CONTENT] Emergency medical services | Emergency medical technician | Decision making | Pre-hospita(...TRUNCATED) | "[CONTENT] Emergency medical services | Emergency medical technician | Decision making | Pre-hospita(...TRUNCATED) | "[CONTENT] Emergency medical services | Emergency medical technician | Decision making | Pre-hospita(...TRUNCATED) | "[CONTENT] Decision Making | Emergency Medical Services | Emergency Medical Technicians | Grounded T(...TRUNCATED) | "[CONTENT] Decision Making | Emergency Medical Services | Emergency Medical Technicians | Grounded T(...TRUNCATED) | "[CONTENT] Decision Making | Emergency Medical Services | Emergency Medical Technicians | Grounded T(...TRUNCATED) | "[CONTENT] Decision Making | Emergency Medical Services | Emergency Medical Technicians | Grounded T(...TRUNCATED) | "[CONTENT] Decision Making | Emergency Medical Services | Emergency Medical Technicians | Grounded T(...TRUNCATED) | "[CONTENT] Decision Making | Emergency Medical Services | Emergency Medical Technicians | Grounded T(...TRUNCATED) | "[CONTENT] effect emts decisions | emergency care concluded | services emts emergency | emt decision(...TRUNCATED) | "[CONTENT] effect emts decisions | emergency care concluded | services emts emergency | emt decision(...TRUNCATED) | "[CONTENT] effect emts decisions | emergency care concluded | services emts emergency | emt decision(...TRUNCATED) | "[CONTENT] effect emts decisions | emergency care concluded | services emts emergency | emt decision(...TRUNCATED) | "[CONTENT] effect emts decisions | emergency care concluded | services emts emergency | emt decision(...TRUNCATED) | "[CONTENT] effect emts decisions | emergency care concluded | services emts emergency | emt decision(...TRUNCATED) | "[CONTENT] emts | decision | making | decision making | scene | emergency | medical | hospital | stu(...TRUNCATED) | "[CONTENT] emts | decision | making | decision making | scene | emergency | medical | hospital | stu(...TRUNCATED) | "[CONTENT] emts | decision | making | decision making | scene | emergency | medical | hospital | stu(...TRUNCATED) | "[CONTENT] emts | decision | making | decision making | scene | emergency | medical | hospital | stu(...TRUNCATED) | "[CONTENT] emts | decision | making | decision making | scene | emergency | medical | hospital | stu(...TRUNCATED) | "[CONTENT] emts | decision | making | decision making | scene | emergency | medical | hospital | stu(...TRUNCATED) | "[CONTENT] decision | scene | making | decision making | emts | morbidity | mortality | morbidity mo(...TRUNCATED) | "[CONTENT] interviews | data | categories | data collection | collection | field | pi | ems | center(...TRUNCATED) | "[CONTENT] emts | decision | trust | making | patient | decision making | hospital | patients | emer(...TRUNCATED) | "[CONTENT] emts | medical | study | model | decision | decision making | process | emergency | makin(...TRUNCATED) | "[CONTENT] emts | decision | making | decision making | scene | emergency | medical | study | hospit(...TRUNCATED) | "[CONTENT] emts | decision | making | decision making | scene | emergency | medical | study | hospit(...TRUNCATED) | [CONTENT] ||| ||| Iranian [SUMMARY] | [CONTENT] ||| 26 | 17 | 1 ||| Interviews | October 2018 to July 2019 ||| Strauss | 2015 [SUMMARY] | [CONTENT] ||| ||| ||| ||| Emergency Medical [SUMMARY] | "[CONTENT] Emergency Medical | the Emergency Medical Technicians ||| the Emergency Medical Technicia(...TRUNCATED) | "[CONTENT] ||| ||| Iranian ||| ||| 26 | 17 | 1 ||| Interviews | October 2018 to July 2019 ||| Str(...TRUNCATED) | "[CONTENT] ||| ||| Iranian ||| ||| 26 | 17 | 1 ||| Interviews | October 2018 to July 2019 ||| Str(...TRUNCATED) |
||||||
Developing a Prediction Score for the Diagnosis of Malignant Pleural Effusion: MPE Score. | 35092368 | "The objective of this study was to develop a diagnostic prediction model for diagnosis of malignant(...TRUNCATED) | BACKGROUND | "Retrospective analysis of pleural fluid cytology was conducted in patients with MPE between 2018 an(...TRUNCATED) | MATERIALS AND METHODS | "The data of pleural fluid cytology from 155 MPE patients were analyzed. Seventy-eight positive pleu(...TRUNCATED) | RESULTS | "The MPE score, as the diagnostic prediction model can be used in planning for more efficient diagno(...TRUNCATED) | CONCLUSIONS | ["Adult","Area Under Curve","Biomarkers, Tumor","Body Fluids","Clinical Decision Rules","Female","Hu(...TRUNCATED) | 9258676 | Introduction | "Malignant pleural effusion (MPE) refers to finding cytology pleural fluid caused by the metastasis (...TRUNCATED) | null | null | Results | "The data of the cytologic results of pleural fluid of 166 patients were collected. Eleven patients (...TRUNCATED) | null | null | [
"Author Contribution Statement",
"Funding Statement"
] | ["Chaichana Chantharakhit: Designed the study, reviewed the paper, collected data, analyzed data, an(...TRUNCATED) | [
null,
null
] | ["Introduction","Materials and Methods","Results","Discussion","Author Contribution Statement","Fund(...TRUNCATED) | ["Malignant pleural effusion (MPE) refers to finding cytology pleural fluid caused by the metastasis(...TRUNCATED) | [
"intro",
"materials|methods",
"results",
"discussion",
null,
null,
"data-availability"
] | [
"MPE score",
"pleural fluid cytology",
"diagnostic prediction model",
"malignant pleural effusion"
] | "Introduction:\nMalignant pleural effusion (MPE) refers to finding cytology pleural fluid caused by (...TRUNCATED) | "Background:\nThe objective of this study was to develop a diagnostic prediction model for diagnosis(...TRUNCATED) | null | null | 2,951 | 327 | [
38,
25
] | 7 | [
"pleural",
"mpe",
"fluid",
"pleural fluid",
"cancer",
"diagnosis",
"data",
"cytology",
"score",
"ratio"
] | ["diagnosis mpe cytology","mpe improved pleuroscopy","cytology pleural effusion","mpe pleural fluid"(...TRUNCATED) | null | null | null | "[CONTENT] MPE score | pleural fluid cytology | diagnostic prediction model | malignant pleural effu(...TRUNCATED) | null | "[CONTENT] MPE score | pleural fluid cytology | diagnostic prediction model | malignant pleural effu(...TRUNCATED) | null | "[CONTENT] MPE score | pleural fluid cytology | diagnostic prediction model | malignant pleural effu(...TRUNCATED) | null | "[CONTENT] Adult | Area Under Curve | Biomarkers, Tumor | Body Fluids | Clinical Decision Rules | Fe(...TRUNCATED) | null | "[CONTENT] Adult | Area Under Curve | Biomarkers, Tumor | Body Fluids | Clinical Decision Rules | Fe(...TRUNCATED) | null | "[CONTENT] Adult | Area Under Curve | Biomarkers, Tumor | Body Fluids | Clinical Decision Rules | Fe(...TRUNCATED) | null | "[CONTENT] diagnosis mpe cytology | mpe improved pleuroscopy | cytology pleural effusion | mpe pleur(...TRUNCATED) | null | "[CONTENT] diagnosis mpe cytology | mpe improved pleuroscopy | cytology pleural effusion | mpe pleur(...TRUNCATED) | null | "[CONTENT] diagnosis mpe cytology | mpe improved pleuroscopy | cytology pleural effusion | mpe pleur(...TRUNCATED) | null | "[CONTENT] pleural | mpe | fluid | pleural fluid | cancer | diagnosis | data | cytology | score | ra(...TRUNCATED) | null | "[CONTENT] pleural | mpe | fluid | pleural fluid | cancer | diagnosis | data | cytology | score | ra(...TRUNCATED) | null | "[CONTENT] pleural | mpe | fluid | pleural fluid | cancer | diagnosis | data | cytology | score | ra(...TRUNCATED) | null | "[CONTENT] mpe | cancer | pleural | cytology | diagnostic | diagnosis | invasive | method | fluid | (...TRUNCATED) | null | "[CONTENT] equal | score | mpe | curve | value | logistic regression | logistic | regression | ratio(...TRUNCATED) | null | "[CONTENT] pleural | mpe | fluid | pleural fluid | financial | data | cancer | diagnosis | cytology (...TRUNCATED) | null | [CONTENT] MPE | pleural fluid | MPE [SUMMARY] | null | "[CONTENT] pleural fluid | 155 | MPE ||| Seventy-eight | 50.32% ||| 66.67% ||| 4.64 | 555 ||| 60 | d(...TRUNCATED) | null | "[CONTENT] MPE | pleural fluid | MPE ||| MPE | between 2018 and 2020 ||| ||| ||| ||| ||| pleural(...TRUNCATED) | null |
|||
A deep neural network using audio files for detection of aortic stenosis. | 35438211 | "Although aortic stenosis (AS) is the most common valvular heart disease in the western world, many (...TRUNCATED) | BACKGROUND | "A deep neural network (DNN) was trained by preprocessed audio files of 100 patients with AS and 100(...TRUNCATED) | METHODS | "Eighteen percent of patients without AS and 22% of patients with AS showed an additional moderate o(...TRUNCATED) | RESULTS | "The present study shows that deep learning-guided auscultation predicts significant AS with similar(...TRUNCATED) | CONCLUSIONS | ["Aortic Valve Stenosis","Cardiologists","Cardiology","Humans","Neural Networks, Computer","Pilot Pr(...TRUNCATED) | 9175247 | BACKGROUND | "After mitral regurgitation, aortic valve stenosis (AS) is the second most common valvular disease.\(...TRUNCATED) | METHODS | "The study consists of two parts. In the first part, we trained a neural network to classify auscult(...TRUNCATED) | RESULTS | "Data from 120 patients with and 120 patients without AS were taken for the present study. From each(...TRUNCATED) | null | null | ["DNN's diagnostic accuracy","Diagnostic accuracy of the CNN versus cardiologists, residents, and st(...TRUNCATED) | ["Hyperparameter tuning was done using K‐fold cross‐validation. The training data were split int(...TRUNCATED) | [
null,
null,
null
] | ["BACKGROUND","METHODS","RESULTS","DNN's diagnostic accuracy","Diagnostic accuracy of the CNN versus(...TRUNCATED) | ["After mitral regurgitation, aortic valve stenosis (AS) is the second most common valvular disease.(...TRUNCATED) | [
"background",
"methods",
"results",
null,
null,
"discussion",
null,
"COI-statement"
] | ["aortic stenosis","artificial intelligence","auscultation","deep neural network","machine learning"(...TRUNCATED) | "BACKGROUND:\nAfter mitral regurgitation, aortic valve stenosis (AS) is the second most common valvu(...TRUNCATED) | "Background:\nAlthough aortic stenosis (AS) is the most common valvular heart disease in the western(...TRUNCATED) | null | null | 4,795 | 268 | [
389,
264,
90
] | 8 | ["auscultation","dnn","patients","data","cardiologists","residents","students","audio","files","audi(...TRUNCATED) | ["valve stenosis second","aortic valve replacement","stenosis patients valvular","aortic stenosis fa(...TRUNCATED) | null | null | "[CONTENT] aortic stenosis | artificial intelligence | auscultation | deep neural network | machine (...TRUNCATED) | "[CONTENT] aortic stenosis | artificial intelligence | auscultation | deep neural network | machine (...TRUNCATED) | "[CONTENT] aortic stenosis | artificial intelligence | auscultation | deep neural network | machine (...TRUNCATED) | null | "[CONTENT] aortic stenosis | artificial intelligence | auscultation | deep neural network | machine (...TRUNCATED) | null | "[CONTENT] Aortic Valve Stenosis | Cardiologists | Cardiology | Humans | Neural Networks, Computer |(...TRUNCATED) | "[CONTENT] Aortic Valve Stenosis | Cardiologists | Cardiology | Humans | Neural Networks, Computer |(...TRUNCATED) | "[CONTENT] Aortic Valve Stenosis | Cardiologists | Cardiology | Humans | Neural Networks, Computer |(...TRUNCATED) | null | "[CONTENT] Aortic Valve Stenosis | Cardiologists | Cardiology | Humans | Neural Networks, Computer |(...TRUNCATED) | null | "[CONTENT] valve stenosis second | aortic valve replacement | stenosis patients valvular | aortic st(...TRUNCATED) | "[CONTENT] valve stenosis second | aortic valve replacement | stenosis patients valvular | aortic st(...TRUNCATED) | "[CONTENT] valve stenosis second | aortic valve replacement | stenosis patients valvular | aortic st(...TRUNCATED) | null | "[CONTENT] valve stenosis second | aortic valve replacement | stenosis patients valvular | aortic st(...TRUNCATED) | null | "[CONTENT] auscultation | dnn | patients | data | cardiologists | residents | students | audio | fil(...TRUNCATED) | "[CONTENT] auscultation | dnn | patients | data | cardiologists | residents | students | audio | fil(...TRUNCATED) | "[CONTENT] auscultation | dnn | patients | data | cardiologists | residents | students | audio | fil(...TRUNCATED) | null | "[CONTENT] auscultation | dnn | patients | data | cardiologists | residents | students | audio | fil(...TRUNCATED) | null | "[CONTENT] population | heart | significant | valve | years | 65 | replacement | mortality | valve r(...TRUNCATED) | "[CONTENT] files | auscultation | audio | patients | data | 10 | test | coefficients | mfcc | convol(...TRUNCATED) | "[CONTENT] students | residents | dnn | cardiologists | patients | point | auscultation | 94 | 93 | (...TRUNCATED) | null | "[CONTENT] auscultation | dnn | students | patients | data | residents | cardiologists | files | aud(...TRUNCATED) | null | [CONTENT] ||| ||| [SUMMARY] | [CONTENT] 100 | AS and 100 ||| 40 ||| F1 ||| [SUMMARY] | "[CONTENT] Eighteen percent | 22% ||| 0.90 | 0.81 | 1 | F1 | 0.95 | 0.89-1.0 ||| F1 | 0.94 | 0.86-1.(...TRUNCATED) | null | "[CONTENT] ||| ||| ||| 100 | AS and 100 ||| 40 ||| F1 ||| ||| Eighteen percent | 22% ||| 0.90 | (...TRUNCATED) | null |
||||
"Skin barrier dysfunction measured by transepidermal water loss at 2 days and 2 months predates and (...TRUNCATED) | 25618747 | "Loss-of-function mutations in the skin barrier protein filaggrin (FLG) are a major risk for atopic (...TRUNCATED) | BACKGROUND | "A total of 1903 infants were enrolled in the Cork Babies After Scope: Evaluating the Longitudinal I(...TRUNCATED) | METHODS | "At 6 months, 18.7% of the children had AD, and at 12 months, 15.53%. In a logistic regression model(...TRUNCATED) | RESULTS | "Impairment of skin barrier function at birth and at 2 months precedes clinical AD. In addition to p(...TRUNCATED) | CONCLUSIONS | ["DNA Mutational Analysis","Dermatitis, Atopic","Female","Filaggrin Proteins","Genotype","Humans","I(...TRUNCATED) | 4382348 | null | null | Methods | " Study subjects The Cork Babies After Scope: Evaluating the Longitudinal Impact Using Neurological(...TRUNCATED) | Results | "A total of 1903 infants were enrolled onto the study. The demographic details of the population stu(...TRUNCATED) | null | null | ["Study subjects","TEWL measurements","Statistical analysis","Filaggrin mutation typing","TEWL throu(...TRUNCATED) | ["The Cork Babies After Scope: Evaluating the Longitudinal Impact Using Neurological and Nutritional(...TRUNCATED) | [
null,
null,
null,
null,
null,
null,
null,
null,
null
] | ["Methods","Study subjects","TEWL measurements","Statistical analysis","Results","Filaggrin mutation(...TRUNCATED) | [" Study subjects The Cork Babies After Scope: Evaluating the Longitudinal Impact Using Neurologica(...TRUNCATED) | [
"methods",
null,
null,
null,
"results",
null,
null,
null,
null,
null,
null,
"discussion"
] | ["Infant","skin barrier","TEWL","atopic dermatitis","filaggrin","predictor","biomarker","AD, Atopic (...TRUNCATED) | "Methods:\n Study subjects The Cork Babies After Scope: Evaluating the Longitudinal Impact Using Ne(...TRUNCATED) | "Background:\nLoss-of-function mutations in the skin barrier protein filaggrin (FLG) are a major ris(...TRUNCATED) | null | null | 7,641 | 401 | [
370,
248,
338,
84,
165,
123,
311,
226,
292
] | 12 | [
"months",
"tewl",
"ad",
"flg",
"12",
"infants",
"12 months",
"model",
"mutation",
"flg mutation"
] | ["term infant postnatal","cork university maternity","birth cohort study","cork baseline birth","inf(...TRUNCATED) | null | null | null | null | "[CONTENT] Infant | skin barrier | TEWL | atopic dermatitis | filaggrin | predictor | biomarker | AD(...TRUNCATED) | "[CONTENT] Infant | skin barrier | TEWL | atopic dermatitis | filaggrin | predictor | biomarker | AD(...TRUNCATED) | null | "[CONTENT] Infant | skin barrier | TEWL | atopic dermatitis | filaggrin | predictor | biomarker | AD(...TRUNCATED) | null | null | "[CONTENT] DNA Mutational Analysis | Dermatitis, Atopic | Female | Filaggrin Proteins | Genotype | H(...TRUNCATED) | "[CONTENT] DNA Mutational Analysis | Dermatitis, Atopic | Female | Filaggrin Proteins | Genotype | H(...TRUNCATED) | null | "[CONTENT] DNA Mutational Analysis | Dermatitis, Atopic | Female | Filaggrin Proteins | Genotype | H(...TRUNCATED) | null | null | "[CONTENT] term infant postnatal | cork university maternity | birth cohort study | cork baseline bi(...TRUNCATED) | "[CONTENT] term infant postnatal | cork university maternity | birth cohort study | cork baseline bi(...TRUNCATED) | null | "[CONTENT] term infant postnatal | cork university maternity | birth cohort study | cork baseline bi(...TRUNCATED) | null | null | "[CONTENT] months | tewl | ad | flg | 12 | infants | 12 months | model | mutation | flg mutation [SU(...TRUNCATED) | "[CONTENT] months | tewl | ad | flg | 12 | infants | 12 months | model | mutation | flg mutation [SU(...TRUNCATED) | null | "[CONTENT] months | tewl | ad | flg | 12 | infants | 12 months | model | mutation | flg mutation [SU(...TRUNCATED) | null | null | "[CONTENT] months | study | recruited | birth | cork | 12 | room | variable | scope | tewl [SUMMARY](...TRUNCATED) | "[CONTENT] tewl | months | model | flg | ad | mutation | infants | day | flg mutation | month [SUMMA(...TRUNCATED) | null | "[CONTENT] months | tewl | ad | flg | infants | model | 12 | mutation | flg mutation | 12 months [SU(...TRUNCATED) | null | null | "[CONTENT] 1903 | the Cork Babies After Scope: Evaluating the Longitudinal Impact Using Neurological(...TRUNCATED) | "[CONTENT] 6 months | 18.7% | 12 months | 15.53% ||| day 2 | TEWL | 12 months | 0.81 ||| day 2 | TEW(...TRUNCATED) | null | "[CONTENT] FLG ||| ||| ||| ||| 1903 | the Cork Babies After Scope: Evaluating the Longitudinal Im(...TRUNCATED) | null |
|||
"In vitro antioxidant and anticancer effects of solvent fractions from Prunella vulgaris var. lilaci(...TRUNCATED) | 24206840 | "Recently, considerable attention has been focused on exploring the potential antioxidant properties(...TRUNCATED) | BACKGROUND | "Dried powder of P. vulgaris var. lilacina was extracted with ethanol, and the extract was fractiona(...TRUNCATED) | METHODS | "The total phenolic contents of the ethanol extract and water fraction of P. vulgaris var. lilacina (...TRUNCATED) | RESULTS | "These results suggest that the ethanol extract from P. vulgaris var. lilacina and its fractions cou(...TRUNCATED) | CONCLUSIONS | ["Analysis of Variance","Animals","Antineoplastic Agents","Antioxidants","Cell Line, Tumor","Cell Su(...TRUNCATED) | 4226201 | Background | "Oxidative stress is caused by reactive oxygen species (ROS), which are associated with many patholo(...TRUNCATED) | Methods | " Reagents The reagents 1,1-diphenyl-1-picrylhydrazyl (DPPH), 2,2′-azinibis 3-ethyl benzothiazoli(...TRUNCATED) | null | null | Conclusions | "The present study determined that P. vulgaris var. lilacina extract and its fractions have strong a(...TRUNCATED) | ["Background","Reagents","Sample preparation and extraction","Total phenolic content","DPPH radical (...TRUNCATED) | ["Oxidative stress is caused by reactive oxygen species (ROS), which are associated with many pathol(...TRUNCATED) | [null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null(...TRUNCATED) | ["Background","Methods","Reagents","Sample preparation and extraction","Total phenolic content","DPP(...TRUNCATED) | ["Oxidative stress is caused by reactive oxygen species (ROS), which are associated with many pathol(...TRUNCATED) | [null,"methods",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null(...TRUNCATED) | [
"Prunella vulgaris var. lilacina",
"Antioxidative activity",
"Anticancer activity"
] | "Background:\nOxidative stress is caused by reactive oxygen species (ROS), which are associated with(...TRUNCATED) | "Background:\nRecently, considerable attention has been focused on exploring the potential antioxida(...TRUNCATED) | "Background:\nOxidative stress is caused by reactive oxygen species (ROS), which are associated with(...TRUNCATED) | "Background:\nRecently, considerable attention has been focused on exploring the potential antioxida(...TRUNCATED) | 13,736 | 452 | [
351,
154,
188,
123,
170,
93,
145,
116,
87,
97,
78,
247,
144,
76,
5083,
38,
234,
770,
182,
940,
355,
78,
10,
58,
16
] | 28 | ["vulgaris var","var lilacina","var","lilacina","vulgaris","vulgaris var lilacina","extract","activi(...TRUNCATED) | ["strong antioxidant activity","antioxidants especially plant","antioxidants vulgaris","extracts hig(...TRUNCATED) | null | [CONTENT] Prunella vulgaris var. lilacina | Antioxidative activity | Anticancer activity [SUMMARY] | [CONTENT] Prunella vulgaris var. lilacina | Antioxidative activity | Anticancer activity [SUMMARY] | null | [CONTENT] Prunella vulgaris var. lilacina | Antioxidative activity | Anticancer activity [SUMMARY] | [CONTENT] Prunella vulgaris var. lilacina | Antioxidative activity | Anticancer activity [SUMMARY] | [CONTENT] Prunella vulgaris var. lilacina | Antioxidative activity | Anticancer activity [SUMMARY] | "[CONTENT] Analysis of Variance | Animals | Antineoplastic Agents | Antioxidants | Cell Line, Tumor (...TRUNCATED) | "[CONTENT] Analysis of Variance | Animals | Antineoplastic Agents | Antioxidants | Cell Line, Tumor (...TRUNCATED) | null | "[CONTENT] Analysis of Variance | Animals | Antineoplastic Agents | Antioxidants | Cell Line, Tumor (...TRUNCATED) | "[CONTENT] Analysis of Variance | Animals | Antineoplastic Agents | Antioxidants | Cell Line, Tumor (...TRUNCATED) | "[CONTENT] Analysis of Variance | Animals | Antineoplastic Agents | Antioxidants | Cell Line, Tumor (...TRUNCATED) | "[CONTENT] strong antioxidant activity | antioxidants especially plant | antioxidants vulgaris | ext(...TRUNCATED) | "[CONTENT] strong antioxidant activity | antioxidants especially plant | antioxidants vulgaris | ext(...TRUNCATED) | null | "[CONTENT] strong antioxidant activity | antioxidants especially plant | antioxidants vulgaris | ext(...TRUNCATED) | "[CONTENT] strong antioxidant activity | antioxidants especially plant | antioxidants vulgaris | ext(...TRUNCATED) | "[CONTENT] strong antioxidant activity | antioxidants especially plant | antioxidants vulgaris | ext(...TRUNCATED) | "[CONTENT] vulgaris var | var lilacina | var | lilacina | vulgaris | vulgaris var lilacina | extract(...TRUNCATED) | "[CONTENT] vulgaris var | var lilacina | var | lilacina | vulgaris | vulgaris var lilacina | extract(...TRUNCATED) | null | "[CONTENT] vulgaris var | var lilacina | var | lilacina | vulgaris | vulgaris var lilacina | extract(...TRUNCATED) | "[CONTENT] vulgaris var | var lilacina | var | lilacina | vulgaris | vulgaris var lilacina | extract(...TRUNCATED) | "[CONTENT] vulgaris var | var lilacina | var | lilacina | vulgaris | vulgaris var lilacina | extract(...TRUNCATED) | "[CONTENT] antioxidants | anti | oxidative | antioxidant | vulgaris | var lilacina | var | vulgaris (...TRUNCATED) | "[CONTENT] solution | absorbance | line | cell line | cell | min | radical | cells | reverse | usa [(...TRUNCATED) | null | "[CONTENT] antioxidant | anticancer | vulgaris | var lilacina | var | vulgaris var lilacina | vulgar(...TRUNCATED) | "[CONTENT] vulgaris | lilacina | var lilacina | vulgaris var lilacina | var | vulgaris var | extract(...TRUNCATED) | "[CONTENT] vulgaris | lilacina | var lilacina | vulgaris var lilacina | var | vulgaris var | extract(...TRUNCATED) | "[CONTENT] ||| ||| Korea | Japan | China | Europe ||| P. vulgaris var ||| ||| P. vulgaris var |||(...TRUNCATED) | [CONTENT] ||| the hexane fraction ||| Folin ||| FRAP | ABTS | SOD ||| MTT ||| RT-PCR [SUMMARY] | null | [CONTENT] P. vulgaris var ||| [SUMMARY] | "[CONTENT] ||| ||| Korea | Japan | China | Europe ||| P. vulgaris var ||| ||| P. vulgaris var |||(...TRUNCATED) | "[CONTENT] ||| ||| Korea | Japan | China | Europe ||| P. vulgaris var ||| ||| P. vulgaris var |||(...TRUNCATED) |
End of preview. Expand
in Dataset Viewer.
- Downloads last month
- 53